CONCLUSIONS: This large prospective clinical study shows that surgical treatment for CSM
is associated with significant improvements in generic and patient-specific outcome
measures at one year, which are sustained at two-year follow up. Surgical treatment
appears to be a highly effective option for patients with symptomatic CSM and is an
approach which can be recommended based on objective outcomes data. FDA
DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices …

BACKGROUND CONTEXT: Advancements in the philosophy of “motion preservation” have
led to the use of total disc arthroplasty (TDA) as an alternative to fusion for degenerative disc
disease (DDD) in the cervical spine. A commonly proposed theory is that TDA could reduce
the incidence of adjacent segment disease. All the published clinical studies for TDA discuss
the “equal efficacy” results of different investigational device exemption (IDE) trials between
TDA and anterior cervical discectomy and fusion (ACDF) but have not addressed the issue …